Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:SILOD)

N/A UNCHANGED
Last Price Updated: 2:33 PM EDT, Sep 26, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about SILOD

Silo Pharma Announces Data Supporting Therapeutic Potential of SPC-14 for Alzheimer’s Disease in Pre-Clinical Study
Dosing study of SPC-14 demonstrates efficacy for increasing memory function 
From Silo Pharma, Inc.
Via GlobeNewswire
Silo Pharma extends research pact for Alzheimer’s and Stress Induced Anxiety Therapeutics
Silo and Columbia University continue research on SPC-14 for Alzheimer’s and SPC-15 for Stress Induced Disorders 
From Silo Pharma, Inc.
Via GlobeNewswire
Silo Pharma Initiates Toxicity Study of its Proprietary Ketamine Formulation for Treatment of Fibromyalgia
From Silo Pharma, Inc.
Via GlobeNewswire
Silo Pharma to Present at the Dawson James Small Cap Growth Conference on October 12
From Silo Pharma, Inc.
Via GlobeNewswire
Silo Pharma Initiates FDA Pre-Investigational New Drug (IND) Package for Time-Released Ketamine Technology
From Silo Pharma, Inc.
Via GlobeNewswire
Silo Pharma Announces Closing of $5.75 Million Public Offering of Common Stock, Nasdaq Listing, and Full Exercise of Underwriter’s Over-Allotment Option
From Silo Pharma, Inc.
Via GlobeNewswire
Psychedelics Feature During Congressional Ways and Means Committee Meeting
Via Investor Brand Network
Researchers Investigate Whether Psilocybin Mushrooms Can Help Combat Obesity
Via Investor Brand Network
New Research Finds Thinning Retina May Signal Onset of Alzheimer’s
Via Investor Brand Network
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.